180 related articles for article (PubMed ID: 15670917)
1. In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand.
Shiba K; Ogawa K; Mori H
Bioorg Med Chem; 2005 Feb; 13(4):1095-9. PubMed ID: 15670917
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor.
Shiba K; Ogawa K; Ishiwata K; Yajima K; Mori H
Bioorg Med Chem; 2006 Apr; 14(8):2620-6. PubMed ID: 16434200
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.
Akhter N; Shiba K; Ogawa K; Kinuya S; Nakajima K; Mori H
Nucl Med Biol; 2007 Aug; 34(6):697-702. PubMed ID: 17707810
[TBL] [Abstract][Full Text] [Related]
4. A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging.
Akhter N; Shiba K; Ogawa K; Tsuji S; Kinuya S; Nakajima K; Mori H
Nucl Med Biol; 2008 Jan; 35(1):29-34. PubMed ID: 18158940
[TBL] [Abstract][Full Text] [Related]
5. Characterization of radioiodinated (-)-ortho-iodovesamicol binding in rat brain preparations.
Shiba K; Yano T; Sato W; Mori H; Tonami N
Life Sci; 2002 Aug; 71(13):1591-8. PubMed ID: 12127913
[TBL] [Abstract][Full Text] [Related]
6. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a radiobromine-labeled sigma ligand for tumor imaging.
Ogawa K; Kanbara H; Kiyono Y; Kitamura Y; Kiwada T; Kozaka T; Kitamura M; Mori T; Shiba K; Odani A
Nucl Med Biol; 2013 May; 40(4):445-50. PubMed ID: 23528561
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of an astatine-211-labeled sigma receptor ligand for alpha radionuclide therapy.
Ogawa K; Mizuno Y; Washiyama K; Shiba K; Takahashi N; Kozaka T; Watanabe S; Shinohara A; Odani A
Nucl Med Biol; 2015 Nov; 42(11):875-9. PubMed ID: 26235266
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of radioiodinated (-)-m-iodovesamicol in rat cerebral membranes.
Shiba K; Mori H; Ichikawa A; Tonami N
Life Sci; 1996; 59(13):1039-45. PubMed ID: 8809223
[TBL] [Abstract][Full Text] [Related]
10. Radioiodinated (-)-2-[4-(3-iodophenyl) piperidino] cyclohexanol: a potential radioligand for mapping presynaptic cholinergic neurons.
Shiba K; Mori H; Matsuda H; Ichikawa A; Tonami N
Nucl Med Commun; 1996 Jun; 17(6):485-92. PubMed ID: 8822746
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site.
Scheunemann M; Sorger D; Wenzel B; Heinitz K; Schliebs R; Klingner M; Sabri O; Steinbach J
Bioorg Med Chem; 2004 Mar; 12(6):1459-65. PubMed ID: 15018919
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes.
Garza HH; Mayo S; Bowen WD; DeCosta BR; Carr DJ
J Immunol; 1993 Nov; 151(9):4672-80. PubMed ID: 7691955
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
John CS; Gulden ME; Vilner BJ; Bowen WD
Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT).
Kozaka T; Uno I; Kitamura Y; Miwa D; Ogawa K; Shiba K
Bioorg Med Chem; 2012 Aug; 20(16):4936-41. PubMed ID: 22831799
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy.
Ogawa K; Shiba K; Akhter N; Yoshimoto M; Washiyama K; Kinuya S; Kawai K; Mori H
Cancer Sci; 2009 Nov; 100(11):2188-92. PubMed ID: 19659515
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
18. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.
Waterhouse RN; Mardon K; Giles KM; Collier TL; O'Brien JC
J Med Chem; 1997 May; 40(11):1657-67. PubMed ID: 9171875
[TBL] [Abstract][Full Text] [Related]
19. Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors.
Moebius FF; Bermoser K; Reiter RJ; Hanner M; Glossmann H
Biochemistry; 1996 Dec; 35(51):16871-8. PubMed ID: 8988026
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of [
Shigeno T; Kozaka T; Kitamura Y; Ogawa K; Taki J; Kinuya S; Shiba K
Ann Nucl Med; 2021 Feb; 35(2):167-175. PubMed ID: 33417152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
